Mostrar el registro sencillo del ítem
dc.contributor.author | Gacimartín García, Begoña | |
dc.contributor.author | Orduna Magán, Carlos | |
dc.contributor.author | Álvarez Peregrina, Cristina | |
dc.contributor.author | Villa Collar, César | |
dc.contributor.author | Sánchez Tena, Miguel Ángel | |
dc.date.accessioned | 2021-05-14T18:06:33Z | |
dc.date.available | 2021-05-14T18:06:33Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | García, B. G., Orduna Magán, C., Alvarez-Peregrina, C., Villa-Collar, C., & Sánchez-Tena, M. Á. (2022). Nd:YAG laser vitreolysis and health-related quality of life in patients with symptomatic vitreous floaters. European Journal of Ophthalmology, 32(2), 1143-1148. https://doi.org/10.1177/11206721211008036 | spa |
dc.identifier.issn | 1120-6721 | |
dc.identifier.issn | 1724-6016 | |
dc.identifier.uri | http://hdl.handle.net/11268/10050 | |
dc.description.abstract | Background: The treatment of floaters has consisted primarily of monitoring. The therapeutic approach is based on surgical removal or Nd:YAG laser treatment. The objective of this study was the assessment of the quality of life in patients treated with Nd:YAG laser for floaters. Methods: Single-center pretest-posttest design in a cohort of subjects treated with Nd-YAG laser with Ultra Q-Reflex technology. Health-related quality of life of the patients was measured before and after the intervention with the Visual Function Questionnaires VFQ-25 and VFQ-39. Anxiety level was measured with the State-Trait Anxiety Inventory. Visual acuity, contrast sensitivity, and safety parameters were also considered. Results: Thirty-four patients were included in the study. For the VFQ-25 baseline, the median was 73.05, interquartile range (19.25) versus a final median value of 93.76 (8.73) with p < 0.01. The baseline median for the extended version VFQ-39 was 74.60 (19.01) versus the final median of 95.01 (6.50) with p < 0.001. Regarding the anxiety, according to the STAI questionnaire, there were statistically significant differences between the baseline and the final conditions, with a baseline median of 38 (11) versus a final median of 18 (19); p < 0.001. When the analyses differentiated between patients with and without myopia, there were statistically significant differences for VFQ-25 and VFQ-39. Conclusions: This study shows an improvement in the health-related quality of life and a significant decrease in anxiety for patients that have undergone Nd: YAG Ultra-Q Reflex laser vitreolysis for floaters vaporization. The effect found is higher in myopic patients. | spa |
dc.description.sponsorship | Sin financiación | spa |
dc.language.iso | eng | spa |
dc.title | Nd:YAG laser vitreolysis and health-related quality of life in patients with symptomatic vitreous floaters | spa |
dc.type | article | spa |
dc.description.impact | 1.7 Q4 JCR 2022 | spa |
dc.description.impact | 0.595 Q2 SJR 2022 | spa |
dc.description.impact | No data IDR 2022 | spa |
dc.identifier.doi | 10.1177/11206721211008036 | |
dc.rights.accessRights | closedAccess | spa |
dc.subject.unesco | Tecnología médica | spa |
dc.subject.unesco | Calidad de vida | spa |
dc.subject.unesco | Oftalmología | spa |
dc.description.filiation | UEM | spa |
dc.relation.publisherversion | https://doi.org/10.1177/11206721211008036 | spa |
dc.peerreviewed | Si | spa |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |